Study of Phosphate Levels in Patients With Chronic Kidney Disease

Completed · Phase 2

Conditions studied: Chronic Kidney Disease

In brief

The purpose of this study is to investigate the ability of different doses of PA21 to lower serum phosphate levels, in patients with chronic kidney disease on maintenance hemodialysis.

Key facts

Study ID
NCT00824460
Run by
Vifor Pharma
People needed
154
Starts
2008-12-01
Expected to finish
2010-03-01
Last updated by the study team
2014-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.